4063.T JPX
Shin-Etsu Chemical Co., Ltd.
1W: +3.8%
1M: +0.1%
3M: -14.0%
YTD: +10.7%
1Y: +36.6%
3Y: +37.3%
5Y: +87.0%
¥6,030.00 ($38.21)
+3.00 (+0.05%)
Weekly Expected Move ±3.1%
¥5660
¥5845
¥6030
¥6215
¥6400
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$5.66T
+0.4% ▲
5Y CAGR: +10.9%
Total Liabilities
$1.02T
+27.5% ▲
5Y CAGR: +15.6%
Shareholders Equity
$4.46T
-4.2% ▼
5Y CAGR: +9.7%
Cash & Investments
$1.67T
-8.0% ▼
5Y CAGR: +7.7%
Total Debt
$243.3B
+617.6% ▲
5Y CAGR: +47.8%
Net Debt
-$1.42T
-66.9% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $1.01T | $1.25T | $590.1B | $882.7B | $1.66T |
| Short-Term Investments | $427.2B | $353.3B | $1.13T | $928.9B | $7.0B |
| Cash & ST Investments | $1.44T | $1.60T | $1.72T | $1.81T | $1.67T |
| Net Receivables | $467.7B | $466.9B | $474.8B | $504.8B | $521.9B |
| Inventory | $453.7B | $688.5B | $720.6B | $770.0B | $790.9B |
| Other Current Assets | $80.5B | $107.5B | $121.4B | $123.2B | $126.2B |
| Total Current Assets | $2.44T | $2.86T | $3.04T | $3.21T | $3.11T |
| Property, Plant & Equip. | $1.29T | $1.52T | $1.75T | $2.07T | $2.15T |
| Goodwill & Intangibles | $10.5B | $10.4B | $10.2B | $36.9B | $34.7B |
| Long-Term Investments | $165.1B | $174.9B | $187.5B | $139.2B | $151.8B |
| Other Non-Current Assets | $84.0B | $88.4B | $95.9B | $94.7B | $117.0B |
| Total Non-Current Assets | $1.62T | $1.87T | $2.11T | $2.43T | $2.56T |
| Total Assets | $4.05T | $4.73T | $5.15T | $5.64T | $5.66T |
| — Liabilities — | |||||
| Accounts Payable | $177.7B | $185.0B | $161.4B | $184.4B | $176.4B |
| Short-Term Debt | $15.0B | $15.0B | $14.8B | $14.5B | $6.9B |
| Deferred Revenue | $0 | $0 | $0 | $3.5B | $0 |
| Other Current Liabilities | $211.3B | $237.4B | $265.7B | $243.7B | $250.1B |
| Total Current Liabilities | $477.8B | $507.8B | $520.4B | $537.1B | $522.6B |
| Long-Term Debt | $16.9B | $18.8B | $13.9B | $7.5B | $236.4B |
| Other Non-Current Liab. | $55.7B | $52.0B | $47.9B | $50.7B | $50.4B |
| Total Non-Current Liabilities | $146.4B | $196.4B | $203.5B | $261.9B | $496.0B |
| Total Liabilities | $624.2B | $704.2B | $723.9B | $799.0B | $1.02T |
| — Equity — | |||||
| Common Stock | $119.4B | $119.4B | $119.4B | $119.4B | $119.4B |
| Retained Earnings | $2.99T | $3.31T | $3.52T | $3.76T | $4.02T |
| Accumulated OCI | $103.5B | $339.2B | $519.4B | $783.1B | $808.9B |
| Total Stockholders Equity | $3.33T | $3.87T | $4.26T | $4.66T | $4.46T |
| Total Liabilities & Equity | $4.05T | $4.73T | $5.15T | $5.64T | $5.66T |
| — Key Metrics — | |||||
| Total Debt | $39.0B | $47.1B | $41.2B | $33.9B | $243.3B |
| Net Debt | -$970.0B | -$1.20T | -$548.9B | -$848.8B | -$1.42T |
| Total Investments | $592.3B | $528.2B | $1.32T | $1.07T | $158.9B |